Literature DB >> 7844393

Interleukin-10 and the monocyte/macrophage-induced inflammatory response in septic shock.

J Gómez-Jiménez1, M C Martín, R Sauri, R M Segura, F Esteban, J C Ruiz, X Nuvials, J L Bóveda, R Peracaula, A Salgado.   

Abstract

Interleukin (IL)-10 is a potent immunosuppressant of monocyte/macrophage function and may help control the inflammatory response induced by bacterial infection. To analyze whether IL-10 is detectable in plasma of patients with septic shock and to evaluate its relationship with endotoxin (lipopolysaccharide [LPS])-induced and monocyte/macrophage-induced inflammatory response, plasma IL-10, tumor necrosis factor (TNF)-alpha, IL-1 beta, IL-6, IL-8, LPS, and neopterin were studied in 24 patients with septic shock and in 12 critically ill patients. Eighty-three percent of patients with septic shock and 25% of critically ill patients had detectable levels of IL-10 (P < .001). There was a significant correlation between plasma IL-10, neopterin (r = .72), TNF-alpha (r = .76), IL-6 (r = .68), and IL-8 (r = .61) levels in patients with septic shock. Monocyte/macrophage activation leads to massive secretion of IL-10, which, however, seems to be unable to control the increased production of proinflammatory mediators during septic shock.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7844393     DOI: 10.1093/infdis/171.2.472

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  14 in total

1.  Interleukin-10-1082 promoter polymorphism in association with cytokine production and sepsis susceptibility.

Authors:  Spaska A Stanilova; Lyuba D Miteva; Zhivko T Karakolev; Chavdar S Stefanov
Journal:  Intensive Care Med       Date:  2006-01-25       Impact factor: 17.440

2.  Sequential changes in the metabolic response in severely septic patients during the first 23 days after the onset of peritonitis.

Authors:  L D Plank; A B Connolly; G L Hill
Journal:  Ann Surg       Date:  1998-08       Impact factor: 12.969

3.  Microbiological and inflammatory effects of murine recombinant interleukin-10 in two models of polymicrobial peritonitis in rats.

Authors:  P Montravers; L Maulin; J Mohler; C Carbon
Journal:  Infect Immun       Date:  1999-04       Impact factor: 3.441

Review 4.  Regulation of interleukin-10 gene expression in macrophages engulfing apoptotic cells.

Authors:  Yan Zhang; Ha-Jeong Kim; Soichiro Yamamoto; Xiaoyan Kang; Xiaojing Ma
Journal:  J Interferon Cytokine Res       Date:  2010-03       Impact factor: 2.607

5.  The septic shock-associated IL-10 -1082 A > G polymorphism mediates allele-specific transcription via poly(ADP-Ribose) polymerase 1 in macrophages engulfing apoptotic cells.

Authors:  Xiaoyan Kang; Ha-Jeong Kim; Michelle Ramirez; Sarah Salameh; Xiaojing Ma
Journal:  J Immunol       Date:  2010-02-24       Impact factor: 5.422

6.  Circulating interleukin 6 and interleukin 10 in community acquired pneumonia.

Authors:  P Glynn; R Coakley; I Kilgallen; N Murphy; S O'Neill
Journal:  Thorax       Date:  1999-01       Impact factor: 9.139

7.  Proinflammatory and anti-inflammatory cytokine responses in preterm infants with systemic infections.

Authors:  P C Ng; K Li; R P O Wong; K Chui; E Wong; G Li; T F Fok
Journal:  Arch Dis Child Fetal Neonatal Ed       Date:  2003-05       Impact factor: 5.747

8.  Tumor necrosis factor alpha upregulates human microglial cell production of interleukin-10 in vitro.

Authors:  W S Sheng; S Hu; F H Kravitz; P K Peterson; C C Chao
Journal:  Clin Diagn Lab Immunol       Date:  1995-09

9.  Alleles carried at positions -819 and -592 of the IL10 promoter affect transcription following stimulation of peripheral blood cells with Streptococcus pneumoniae.

Authors:  Suzanna E L Temple; Esther Lim; Karey Y Cheong; Coral-Ann M Almeida; Patricia Price; Kristin G Ardlie; Grant W Waterer
Journal:  Immunogenetics       Date:  2003-11-06       Impact factor: 2.846

10.  IL-10 helps control pathogen load during high-level bacteremia.

Authors:  Diana Londoño; Adriana Marques; Ronald L Hornung; Diego Cadavid
Journal:  J Immunol       Date:  2008-08-01       Impact factor: 5.422

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.